{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:35Z","timestamp":1707525335578},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,24]]},"DOI":"10.7759\/cureus.47580","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T16:11:22Z","timestamp":1698163882000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Ceftaroline-Associated Thrombocytopenia"],"prefix":"10.7759","author":[{"given":"Ashwin","family":"Jagadish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samra","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahnawaz","family":"Notta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Vedantam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neethu","family":"Vedantam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.10.027","article-title":"Etiologies of thrombocytopenia in the community hospital: the experience of 1 hematologist","volume":"133","author":"Boxer M","year":"2020","unstructured":"Boxer M, Biuso TJ. Etiologies of thrombocytopenia in the community hospital: the experience of 1 hematologist. Am J Med. 2020, 133:e183-6. 10.1016\/j.amjmed.2019.10.027","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2017.1335156","article-title":"New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach","volume":"7","author":"Ali N","year":"2017","unstructured":"Ali N, Auerbach HE. New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach. J Community Hosp Intern Med Perspect. 2017, 7:157-67. 10.1080\/20009666.2017.1335156","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref3","article-title":"Cephalosporins","author":"Bui T","year":"2023","unstructured":"Bui T, Preuss CV. Cephalosporins. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref4","unstructured":"Ceftaroline injection. (2022). Accessed. September 8, 2023: https:\/\/medlineplus.gov\/druginfo\/meds\/a611014.html."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019835208","article-title":"Ceftaroline-induced thrombocytopenia: a case report","volume":"53","author":"Britt RS","year":"2019","unstructured":"Britt RS, Pearson JC, Mahoney MV, Carlson AA. Ceftaroline-induced thrombocytopenia: a case report. Ann Pharmacother. 2019, 53:762-3. 10.1177\/1060028019835208","journal-title":"Ann Pharmacother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul T","year":"2018","unstructured":"Bakchoul T, Marini I. Drug-associated thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2018, 2018:576-83. 10.1182\/asheducation-2018.1.576","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019879086","article-title":"Severe ceftaroline-induced thrombocytopenia with rapid onset on rechallenge","volume":"54","author":"Marler J","year":"2020","unstructured":"Marler J, Twilla JD, Finch CK, Animalu C. Severe ceftaroline-induced thrombocytopenia with rapid onset on rechallenge. Ann Pharmacother. 2020, 54:187-8. 10.1177\/1060028019879086","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016667583","article-title":"High incidence of adverse effects with extended use of ceftaroline","volume":"50","author":"Dellabella A","year":"2016","unstructured":"Dellabella A, Roshdy D, Martin KE. High incidence of adverse effects with extended use of ceftaroline. Ann Pharmacother. 2016, 50:1068-9. 10.1177\/1060028016667583","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1435","article-title":"High incidence of discontinuations due to adverse events in patients treated with ceftaroline","volume":"34","author":"Jain R","year":"2014","unstructured":"Jain R, Chan JD, Rogers L, Dellit TH, Lynch JB, Pottinger PS. High incidence of discontinuations due to adverse events in patients treated with ceftaroline. Pharmacotherapy. 2014, 34:758-63. 10.1002\/phar.1435","journal-title":"Pharmacotherapy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/195534-a-case-of-ceftaroline-associated-thrombocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:02Z","timestamp":1707509462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/195534-a-case-of-ceftaroline-associated-thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.47580","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,24]]}}}